<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Noncoding RNA</journal-id><journal-id journal-id-type="iso-abbrev">Noncoding RNA</journal-id><journal-id journal-id-type="publisher-id">ncrna</journal-id><journal-title-group><journal-title>Non-Coding RNA</journal-title></journal-title-group><issn pub-type="epub">2311-553X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407595</article-id><article-id pub-id-type="pmc">PMC12101189</article-id>
<article-id pub-id-type="doi">10.3390/ncrna11030037</article-id><article-id pub-id-type="publisher-id">ncrna-11-00037</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>Expression of miRNAs in the Relationship Between Periodontitis and Cardiovascular Diseases: A Systematic Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Guerrero-Sabater</surname><given-names>Montiel</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cos&#x000ed;n-Villanueva</surname><given-names>Mar&#x000ed;a</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5284-8535</contrib-id><name><surname>Almi&#x000f1;ana-Pastor</surname><given-names>Pedro</given-names></name><xref rid="c1-ncrna-11-00037" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9335-5948</contrib-id><name><surname>L&#x000f3;pez-Rold&#x000e1;n</surname><given-names>Andr&#x000e9;s</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Wang</surname><given-names>Hsiuying</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Taguchi</surname><given-names>Y-h.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-ncrna-11-00037">Department of Stomatology, Faculty of Medicine and Odontology, University of Valencia, 46010 Valencia, Spain; <email>monguesa@alumni.uv.es</email> (M.G.-S.); <email>mariacosin27@gmail.com</email> (M.C.-V.); <email>andres.lopez-roldan@uv.es</email> (A.L.-R.)</aff><author-notes><corresp id="c1-ncrna-11-00037"><label>*</label>Correspondence: <email>pedro.alminana@uv.es</email>; Tel.: +34-636608233</corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>11</volume><issue>3</issue><elocation-id>37</elocation-id><history><date date-type="received"><day>30</day><month>3</month><year>2025</year></date><date date-type="rev-recd"><day>01</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>02</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Objectives: Periodontitis is a chronic inflammatory disease that could influence the pathophysiology of cardiovascular diseases through immunoinflammatory and epigenetic mechanisms. MicroRNAs (miRNAs) could be key mediators in this interaction, regulating gene expression and the synthesis of inflammatory molecules. The objective of this systematic review was to evaluate the relationship between periodontitis and cardiovascular diseases by analyzing the expression of miRNAs involved in both pathologies. Methods: A systematic search was performed in the PubMed, Scopus, Embase, and Web of Science databases following the PRISMA guidelines. A total of 320 studies were identified, of which seven were included after applying eligibility criteria. Data on study design, sample characteristics, periodontal and cardiovascular diagnostic methodology, and the analyzed miRNAs were extracted. Results: The included studies were observational case-control studies in humans (<italic toggle="yes">n</italic> = 5) and experimental studies in animal models (<italic toggle="yes">n</italic> = 3). The miRNAs selected by the studies to link both pathologies were miR-155, miR-155-5p, miR-146a, miR-143, miR-145, and miR-23b. Most studies observed the overexpression of these miRNAs in patients with periodontitis and cardiovascular disease, with miR-146a being the most frequently associated. Conclusions: The findings suggest that certain miRNAs, particularly miR-146a, may play a key role in the connection between periodontitis and cardiovascular disease. Its overexpression in patients with both pathologies reinforces the hypothesis of its involvement in the inflammatory processes associated with both conditions. It would be interesting to conduct studies to validate their clinical applicability as biomarkers of susceptibility to cardiovascular disease.</p></abstract><kwd-group><kwd>cardiovascular disease</kwd><kwd>epigenetics</kwd><kwd>microRNA</kwd><kwd>periodontitis</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-ncrna-11-00037"><title>1. Introduction</title><p>Periodontitis is a chronic, inflammatory, and multifactorial disease whose primary etiological factor is bacterial plaque. Its progression is significantly influenced by host risk factors. Clinically, periodontitis presents periodontal pockets, gingival bleeding, and destruction of the tooth-supporting apparatus or periodontium, which consists of the periodontal ligament, connective tissue attachment, and alveolar bone. Consequently, this leads to clinical attachment loss, measured through the clinical parameter probing depth [<xref rid="B1-ncrna-11-00037" ref-type="bibr">1</xref>]. Persistent or chronic periodontal inflammation results in sustained secretion of proinflammatory mediators, causing tissue damage, bone resorption, and disease progression. This inflammation creates an altered environment both locally and systemically, thereby exacerbating systemic conditions such as diabetes [<xref rid="B2-ncrna-11-00037" ref-type="bibr">2</xref>] and cardiovascular diseases [<xref rid="B3-ncrna-11-00037" ref-type="bibr">3</xref>]. The association between periodontitis and various systemic diseases such as diabetes, obesity, Alzheimer&#x02019;s, and cardiovascular diseases has been extensively studied in recent years [<xref rid="B2-ncrna-11-00037" ref-type="bibr">2</xref>,<xref rid="B3-ncrna-11-00037" ref-type="bibr">3</xref>].</p><p>Cardiovascular diseases encompass various cardiac and vascular conditions, including ischemia, atherosclerosis, peripheral arterial disease, infectious endocarditis, and acute myocardial infarction. Among these, atherosclerosis is a condition that can lead to both ischemia and acute myocardial infarction due to blood flow obstruction [<xref rid="B4-ncrna-11-00037" ref-type="bibr">4</xref>,<xref rid="B5-ncrna-11-00037" ref-type="bibr">5</xref>].</p><p>The pathophysiological pathways involved in the interaction between periodontal pathogens and atheroma plaque formation are related to the effects of bacteria on platelets, autoimmune responses (antibodies), and the invasion and/or absorption of bacteria (<italic toggle="yes">Porphyromonas gingivalis</italic> via its <italic toggle="yes">fimbriae</italic>) into endothelial cells and macrophages [<xref rid="B6-ncrna-11-00037" ref-type="bibr">6</xref>,<xref rid="B7-ncrna-11-00037" ref-type="bibr">7</xref>,<xref rid="B8-ncrna-11-00037" ref-type="bibr">8</xref>].</p><p>The role of genetics in the predisposition to both diseases has not been clearly established according to the current research. Genetics has failed to identify individuals susceptible to developing both comorbidities, likely due to the static nature of genetic markers. Therefore, in these chronic inflammatory diseases, epigenetic markers may represent a turning point in understanding their etiopathogenesis and susceptibility. These epigenetic markers are not static and, thus, can define changes in the cellular environment. In these chronic inflammatory conditions, the cellular microenvironment is exposed to various environmental stimuli that significantly influence the host&#x02019;s immunoinflammatory response [<xref rid="B9-ncrna-11-00037" ref-type="bibr">9</xref>].</p><p>Although numerous studies have attempted to identify specific genes involved in the immunoinflammatory mechanisms linking periodontitis and cardiovascular diseases, the results have been inconsistent and inconclusive. In this context, epigenetics&#x02014;and more specifically, miRNAs&#x02014;could provide a key approach to understanding how environmental and molecular factors modulate gene expression without altering DNA sequences, thereby mediating the regulation of inflammatory processes [<xref rid="B10-ncrna-11-00037" ref-type="bibr">10</xref>,<xref rid="B11-ncrna-11-00037" ref-type="bibr">11</xref>,<xref rid="B12-ncrna-11-00037" ref-type="bibr">12</xref>].</p><p>The aim of this study was to analyze the relationship between periodontitis and cardiovascular diseases and to identify the miRNAs involved in the association between both conditions.</p></sec><sec sec-type="results" id="sec2-ncrna-11-00037"><title>2. Results</title><sec id="sec2dot1-ncrna-11-00037"><title>2.1. Study Selection and PRISMA Flow Diagram</title><p>Following the application of the search strategy across different databases, a total of 75 records were identified in Embase, 44 in PubMed, 87 in Scopus, and 114 in Web of Science. After removing duplicates (<italic toggle="yes">n</italic> = 144), 176 studies remained for title and abstract screening. At this stage, 134 studies were excluded, primarily because they were narrative reviews or did not align with the PECO framework of this systematic review.</p><p>A total of 42 studies met the inclusion criteria. After full-text assessment, 34 studies were excluded for the following reasons: investigation of different genetic mechanisms (<italic toggle="yes">n</italic> = 7) or unrelated diseases (<italic toggle="yes">n</italic> = 4), absence of a control group (<italic toggle="yes">n</italic> = 6), publication in languages other than English or Spanish (<italic toggle="yes">n</italic> = 5), or classification as systematic reviews (<italic toggle="yes">n</italic> = 12).</p><p>Ultimately, eight studies were included in the qualitative synthesis. The PRISMA flow diagram illustrates the article selection process (<xref rid="ncrna-11-00037-f001" ref-type="fig">Figure 1</xref>).</p></sec><sec id="sec2dot2-ncrna-11-00037"><title>2.2. Qualitative Synthesis of Included Studies</title><p><xref rid="ncrna-11-00037-t001" ref-type="table">Table 1</xref> illustrates the extracted data from human studies. All of them were observational case-control studies. Sample sizes ranged from 37 [<xref rid="B13-ncrna-11-00037" ref-type="bibr">13</xref>] to 264 [<xref rid="B14-ncrna-11-00037" ref-type="bibr">14</xref>].</p><p>In all human studies, miRNA expression was compared between patients with both periodontitis and cardiovascular disease and healthy controls for both conditions. Additionally, the studies by Mahendra et al. (2021) [<xref rid="B15-ncrna-11-00037" ref-type="bibr">15</xref>] and Yagnik et al. (2019) described the cardiovascular parameters assessed [<xref rid="B16-ncrna-11-00037" ref-type="bibr">16</xref>].</p><p>For periodontal diagnosis, three out of the four studies used the 1999 Armitage classification, while one study applied the current 2018 Classification of Periodontal and Peri-Implant Diseases and Conditions [<xref rid="B17-ncrna-11-00037" ref-type="bibr">17</xref>].</p><p>On the other hand, <xref rid="ncrna-11-00037-t002" ref-type="table">Table 2</xref> summarizes the data from animal experimental studies. In this case, sample sizes ranged from 16 [<xref rid="B18-ncrna-11-00037" ref-type="bibr">18</xref>] to 25 [<xref rid="B19-ncrna-11-00037" ref-type="bibr">19</xref>]. All selected animals were male ApoE&#x02212;/&#x02212; mice. Moreover, in one of the studies, a gingival biopsy was performed [<xref rid="B20-ncrna-11-00037" ref-type="bibr">20</xref>].</p><p>The miRNAs analyzed in the included studies were as follows:<list list-type="simple"><list-item><label>-</label><p>miR-155</p></list-item><list-item><label>-</label><p>miR-155-5p</p></list-item><list-item><label>-</label><p>miRNA-146a</p></list-item><list-item><label>-</label><p>miR-143</p></list-item><list-item><label>-</label><p>miR-145</p></list-item><list-item><label>-</label><p>miR-23b</p></list-item><list-item><label>-</label><p>miR-126</p></list-item></list></p><p>According to the included studies, most of the analyzed miRNAs were overexpressed in patients with periodontitis or in mice infected with periodontal pathogens and presenting cardiovascular disease, with miR-146a being the most frequently investigated [<xref rid="B14-ncrna-11-00037" ref-type="bibr">14</xref>,<xref rid="B15-ncrna-11-00037" ref-type="bibr">15</xref>,<xref rid="B16-ncrna-11-00037" ref-type="bibr">16</xref>,<xref rid="B18-ncrna-11-00037" ref-type="bibr">18</xref>,<xref rid="B19-ncrna-11-00037" ref-type="bibr">19</xref>]. However, only one of them reported low levels of miR-126 in patients with both cardiovascular and periodontal disease [<xref rid="B15-ncrna-11-00037" ref-type="bibr">15</xref>].</p></sec><sec id="sec2dot3-ncrna-11-00037"><title>2.3. Quality Assessment</title><p>A risk of bias analysis was conducted for the observational human studies (<xref rid="ncrna-11-00037-t003" ref-type="table">Table 3</xref>) using the Newcastle&#x02013;Ottawa Scale (NOS). Overall, the quality assessment indicated high-quality studies, as most received &#x02265;7 stars, suggesting a low risk of bias.</p><p>Additionally, <xref rid="ncrna-11-00037-t004" ref-type="table">Table 4</xref> presents the quality assessment for in vitro and animal studies using the SYRCLE&#x02019;s Risk of Bias Tool. The three evaluated studies exhibited a moderate to high risk of bias, primarily due to insufficient information on randomization, blinding, and sample selection&#x02014;key factors in ensuring internal validity in animal model studies [<xref rid="B21-ncrna-11-00037" ref-type="bibr">21</xref>].
<table-wrap position="anchor" id="ncrna-11-00037-t001"><object-id pub-id-type="pii">ncrna-11-00037-t001_Table 1</object-id><label>Table 1</label><caption><p>Characteristics and main results of included human studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author and Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample Size</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Study</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Periodontal Stage and Grade</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Studied miRNAs</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Other Studied Markers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Sample</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Periodontal Parameter Results</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">miRNA Expression Results</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zina A. Daily et al. (2023)<break/>[<xref rid="B22-ncrna-11-00037" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Irak</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 120<break/>G1 (C): <italic toggle="yes">n</italic> = 30<break/>G2 (P without AS): <italic toggle="yes">n</italic> = 30:<break/>G3 (AS without P): <italic toggle="yes">n</italic> = 30<break/>G4 (AS + P): <italic toggle="yes">n</italic> = 30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case-control</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stages III and IV<break/>Grades B and C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">miR-155</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-1b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blood analysis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-1&#x003b2; higher in G2, G3, and G4 compared to G1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of miR-155 in G2, G3 and G4 compared to G1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wen-Wen Yang et al. (2024)<break/>[<xref rid="B13-ncrna-11-00037" ref-type="bibr">13</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 37<break/>PLASMA SAMPLES FOR SEQUENCING ANALYSIS: <italic toggle="yes">n</italic> = 12:<break/>-G1(CP without CAS): <italic toggle="yes">n</italic> = 6<break/>-G2 (CP + CAS): <italic toggle="yes">n</italic> = 6<break/>PCR ANALYSIS (PLASMA): <italic toggle="yes">n</italic> = 25):<break/>- G3 (low/moderate CP without CAS): <italic toggle="yes">n</italic> = 6<break/>- G4 (severe CP): <italic toggle="yes">n</italic> = 6<break/>- G5 (low/moderate CP + CAS): <italic toggle="yes">n</italic> = 6<break/>- G6 (severe CP + CAS): <italic toggle="yes">n</italic> = 7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case-control</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic periodontitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">miR-155-5p</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasma samples</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of miR-155-5p in CP + CAS compared to CP alone<break/>miR-155-5p overexpressed in plasma exosomes of patients with carotid atherosclerosis (CAS) + chronic periodontitis (CP) and in CAS tissue samples</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Krutika Yagnik et al. (2019)<break/>[<xref rid="B16-ncrna-11-00037" ref-type="bibr">16</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 90<break/>G1 (CP + CDH): <italic toggle="yes">n</italic> = 30<break/>G2 (CP without CDH): <italic toggle="yes">n</italic> = 30<break/>G3 (HP): <italic toggle="yes">n</italic> = 30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case-control</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic periodontitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">miR-146a</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PI, BOP, PPD, CAL<break/>Cardiovascular parameters: cholesterol, high- and low-density lipoproteins, triglycerides, systolic and diastolic blood pressure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Subgingival plaque samples collected with Gracey curettes (Hu-Friedy)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of miRNA-146a and elevated cardiovascular and periodontal parameters in G1 compared to G2 and G3<break/>Higher parameters in G2 compared to G3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">J. Bagavad Gita et al. (2018)<break/>[<xref rid="B14-ncrna-11-00037" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 264<break/>G1 (ACS without CP): <italic toggle="yes">n</italic> = 66<break/>G2 (ACS + CP): <italic toggle="yes">n</italic> = 66<break/>G3 (CP without ACS): <italic toggle="yes">n</italic> = 66<break/>G4 (HP): <italic toggle="yes">n</italic> = 66</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case-control</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate and severe chronic periodontitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">miR-146a</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF-a, IL-1&#x003b2;, IL-6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blood analysis and subgingival plaque samples collected with a sterile paper point</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G1 overexpression (<italic toggle="yes">p</italic> &#x0003c; 0.001) compared to G3 and G4<break/>G4 showed a minimal level of cytokine expression</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of miR-146a in of G2<break/>miR-146a expressions were higher (G1, G2, and G3) compared to G4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mahendra et al. (2021)<break/>[<xref rid="B15-ncrna-11-00037" ref-type="bibr">15</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 75<break/>G1 (GP + CAD) <italic toggle="yes">n</italic> = 25.<break/>- G1a (<italic toggle="yes">n</italic> = 25): subgingival plaques samples<break/>- G1b (<italic toggle="yes">n</italic> = 25): coronary plaque samples at the time of CABG<break/>- G2 (GP) <italic toggle="yes">n</italic> = 25<break/>- G3 (HP) <italic toggle="yes">n</italic> = 25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case-control</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic periodontitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">miR-146a and miR-126</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PI, BOP, PPD, CAL<break/>Cardiovascular parameters: SP, DP, HDL-c, LDL-c, TG, TC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Subgingival plaque samples collected with Gracey&#x02019;s curette<break/>Coronary plaque samples were obtained at the time of CABG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of miR-146a and downregulation of miR-126 in G1</td></tr></tbody></table><table-wrap-foot><fn><p>G: group, CABG: coronary, artery bypass grafting surgery, miR: microRNA, HP: periodontally healthy, C: control, AS: aterosclerosis, P: periodontitis, CP: chronic periodontitis, CAS: carotid aterosclerosis, CDH: coronary heart disease, IP: plaque index, BOP: bleeding on probing, PPD: periodontal probing depth, CAL: clinical attachment level, TNF-a tumor necrosis factor-alpha, IL-1&#x003b2;: interleukin-1&#x003b2;, IL-6: interleukin-6, SP: systolic blood pressure, DP: diastolic blood pressure, HDL-c: high-density lipoprotein levels, LDL-c: low-density lipoprotein levels, TG: total triglyceride levels, TC: total cholesterol levels, <italic toggle="yes">P. gingivalis</italic>: <italic toggle="yes">Porphyromona gingivalis</italic>.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="anchor" id="ncrna-11-00037-t002"><object-id pub-id-type="pii">ncrna-11-00037-t002_Table 2</object-id><label>Table 2</label><caption><p>Characteristics and main results of included experimental studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author and Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample Size</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Study</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Sample</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Studied miRNAs</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Other Studied Markers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">miRNA Expression Results</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Conclusions</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jieyu Zhou et al. (2022)<break/>[<xref rid="B18-ncrna-11-00037" ref-type="bibr">18</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 16<break/>(6-week-old male ApoE &#x02212;/&#x02212; mice)<break/>G1 (infected group): <italic toggle="yes">n</italic> = 8<break/>Oral inoculation of <italic toggle="yes">Fusobacterium nucleatum</italic> in 100 &#x003bc;L of 4% CMC-PBS<break/>G2 (control): <italic toggle="yes">n</italic> = 8<break/>100 &#x003bc;L of 4% CMC-PBS without bacteria (sterile vehicle)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Experimental</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">miR-146a, miR-23b and miR-155</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-6, IL-1&#x003b2;, TNF-a, MCP-1, PCR, ox-LDL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">miR-146a, miR-155, and miR-23b showed elevated levels in serum and aortic tissues of infected mice, although miR-155 expression in the aorta was not significantly higher</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serum levels of pro-atherosclerotic factors and microRNAs (miR-146a, miR-155, miR-23b) significantly increased after <italic toggle="yes">F. nucleatum</italic> stimulation, while HDL-c levels decreased</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Md A. Nahid et al. (2011)<break/>[<xref rid="B19-ncrna-11-00037" ref-type="bibr">19</xref>] </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 25<break/>(male ApoE &#x02212;/&#x02212; mice)<break/>G1 (infected group): <italic toggle="yes">n</italic> = 15:<break/>G2 (control): <italic toggle="yes">n</italic> = 10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Experimental</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">miR-146a</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF-a, IL-1&#x003b2;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of miR-146a in spleens of mice infected with periodontal pathogens compared to the spleens of controls<break/>Upregulation of miR-146a in the maxilla of mice exposed to <italic toggle="yes">P. gingivalis</italic>, <italic toggle="yes">T. denticola</italic>, and <italic toggle="yes">T. forsythia</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hanyu Xie et al. (2023)<break/>[<xref rid="B20-ncrna-11-00037" ref-type="bibr">20</xref>] </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 18<break/>G1 (control mice ApoE&#x02212;/&#x02212; infected with <italic toggle="yes">P. gingivalis</italic>): <italic toggle="yes">n</italic> = 6<break/>G2 (miR-143/145-deficient mice group: miR-143/145&#x02212;/&#x02212;ApoE&#x02212;/&#x02212;): <italic toggle="yes">n</italic> = 6<break/>G3 (miR-143/145 overexpression mice group in LysM lineage cells (ApoE&#x02212;/&#x02212;LysMcre + rAAV9-miR-143/145): <italic toggle="yes">n</italic> = 6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Experimental</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gingival biopsy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">miR-143/145</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of miR-143/145 in G3: Atherosclerotic lesions, osteoclasts, and apoptotic cells were significantly increased compared to G1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><fn><p>G: group, CMC-PBS: carboxymethyl cellulose, miR: microRNA, TNF-a tumor necrosis factor-alpha, IL-1&#x003b2;: interleukin-1&#x003b2;, IL-6: interleukin-6, HDL-c: high-density lipoprotein levels, MCP-1: monocyte chemoattractant protein-1, PCR: polymerase chain reaction, ox-LDL: oxidized low-density lipoprotein, ApoE: apolipoprotein E knockout, LysM: lysosome M, <italic toggle="yes">P. gingivalis</italic>: <italic toggle="yes">Porphyromona gingivalis</italic>, rAAV9: recombinant adeno-associated virus serotype 9.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="anchor" id="ncrna-11-00037-t003"><object-id pub-id-type="pii">ncrna-11-00037-t003_Table 3</object-id><label>Table 3</label><caption><p>Quality assessment of observational studies based on the Newcastle&#x02013;Ottawa Quality Assessment Scale (NOS).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Selection</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Comparability</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Exposure</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case-Control Study</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case Definition *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Representativeness of the Cases *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Selection of Controls *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Definition of Controls *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The Groups Are Comparable, and the Most Important Confounding Factor Is Controlled *, as Well as Other Factors **</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ascertainment of Exposure *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Same Method of Ascertainment for Cases and Controls *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-Response Rate *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zina A. Daily et al. (2023) [<xref rid="B22-ncrna-11-00037" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8/9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wen-Wen Yang et al. (2024) [<xref rid="B13-ncrna-11-00037" ref-type="bibr">13</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5/9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Krutika Yagnik et al. (2019) [<xref rid="B16-ncrna-11-00037" ref-type="bibr">16</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">**</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9/9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">J. Bagavad Gita et al. (2018) [<xref rid="B14-ncrna-11-00037" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7/9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mahendra et al. (2021) [<xref rid="B15-ncrna-11-00037" ref-type="bibr">15</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">*</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8/9</td></tr></tbody></table></table-wrap>
<table-wrap position="anchor" id="ncrna-11-00037-t004"><object-id pub-id-type="pii">ncrna-11-00037-t004_Table 4</object-id><label>Table 4</label><caption><p>Quality assessment of experimental studies based on the SYRCLE&#x02019;s Risk of Bias Tool.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Domain</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Question</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Jieyu Zhou et al. (2022) [<xref rid="B18-ncrna-11-00037" ref-type="bibr">18</xref>]</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Md A. Nahid et al. (2011) [<xref rid="B19-ncrna-11-00037" ref-type="bibr">19</xref>]</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hanyu Xie et al. (2023) [<xref rid="B20-ncrna-11-00037" ref-type="bibr">20</xref>]</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Animal Selection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Was the allocation sequence adequately generated and applied?</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Baseline Characteristics</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Were the groups similar at baseline, or were confounding factors adjusted for in the analysis?</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Allocation Concealment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Was the allocation to different groups adequately concealed?</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Investigator Blinding</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Were the animals randomly housed during the experiment?</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Outcome Assessor Blinding</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Were the caregivers and/or investigators blinded to the intervention each animal received during the experiment?</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Incomplete Data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Were animals randomly selected for outcome assessment?</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Selective Reporting</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Was the outcome assessor blinded?</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Housing Conditions</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Were incomplete outcome data adequately addressed?</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Funding Sources and Conflicts of Interest</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Were the study reports free from selective outcome reporting?</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Other Biases</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Was the study apparently free from other issues that could result in a high risk of bias?</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td></tr></tbody></table></table-wrap></p></sec></sec><sec sec-type="discussion" id="sec3-ncrna-11-00037"><title>3. Discussion</title><p>MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression through post-transcriptional modulation of messenger RNA (mRNA). By participating in the regulation of various cellular processes, including inflammation, immunity, and disease development, their alteration has been linked to multiple pathologies, including periodontitis. Furthermore, their detection in biological fluids such as saliva, gingival crevicular fluid (GCF), and plasma makes them ideal biomarkers for the diagnosis and treatment of chronic inflammatory diseases, such as periodontitis. Therefore, this review was conducted to identify and analyze miRNAs simultaneously involved in both periodontitis and cardiovascular disease.</p><p>The sample size in observational human studies by Wen-Wen Yang et al. (2024) (<italic toggle="yes">N</italic> = 37) [<xref rid="B13-ncrna-11-00037" ref-type="bibr">13</xref>] and Krutika Yagnik et al. (2019) (<italic toggle="yes">N</italic> = 90) [<xref rid="B16-ncrna-11-00037" ref-type="bibr">16</xref>] was limited. Similarly, experimental animal studies by Jie-yu Zhou et al. (2022) (<italic toggle="yes">N</italic> = 16) [<xref rid="B18-ncrna-11-00037" ref-type="bibr">18</xref>], Md A. Nahid et al. (2011) (<italic toggle="yes">N</italic> = 25) [<xref rid="B19-ncrna-11-00037" ref-type="bibr">19</xref>], and Hanyu Xie et al. (2023) (<italic toggle="yes">N</italic> = 24) [<xref rid="B20-ncrna-11-00037" ref-type="bibr">20</xref>] also had small sample sizes. A small sample size may affect the validity of the results and compromise their reproducibility, limiting the generalization of conclusions.</p><p>Regarding diagnostic methods for sample collection, blood and plasma sample analyses were the most common. Only Krutika Yagnik et al. (2019) [<xref rid="B16-ncrna-11-00037" ref-type="bibr">16</xref>] analyzed subgingival plaque, while Hanyu Xie et al. (2023) [<xref rid="B20-ncrna-11-00037" ref-type="bibr">20</xref>] was the only experimental study that performed gingival biopsies. Biopsy is a more invasive procedure, diminishing the value of these miRNAs as biomarkers. GCF is a transudate derived from plasma that is localized in the periodontium. Additionally, it is directly related to periodontal inflammation, increasing in volume and undergoing qualitative molecular changes in the presence of pathology. Analyzing these miRNAs in GCF and assessing their potential to reflect systemic pathologies could be a promising avenue for further research [<xref rid="B23-ncrna-11-00037" ref-type="bibr">23</xref>].</p><p>Among the miRNAs studied in this systematic review, miRNA-146a stood out as a key regulator of inflammation by modulating the immune response through inhibition of the NF-&#x003ba;B pathway, a transcription factor directly involved in the activation of pro-inflammatory cytokines such as TNF-&#x003b1;, IL-1&#x003b2;, and IL-6, among others [<xref rid="B24-ncrna-11-00037" ref-type="bibr">24</xref>]. However, its role in periodontitis remains under investigation due to the complexity of the molecular interactions involved in this pathology.</p><p>J. Bagavad Gita et al. (2018) [<xref rid="B14-ncrna-11-00037" ref-type="bibr">14</xref>] analyzed the regulatory role of miR-146a in the immune-inflammatory response in patients with periodontitis and acute coronary syndrome. This microRNA was overexpressed in all patient groups. However, despite its negative regulatory effect on NF-&#x003ba;B, an increase in IL-1&#x003b2; and TNF-&#x003b1; expression was also observed, suggesting that its inhibitory action is insufficient to effectively reduce inflammation and that additional mechanisms and inflammatory molecules likely mediate this regulatory process.</p><p>This apparent contradiction can be explained by the complexity of the inflammatory signaling network. NF-&#x003ba;B activation is not solely dependent on miR-146a but can be induced by multiple stimuli, such as bacterial lipopolysaccharides (LPS), Toll-like receptors (TLR2 and TLR4), and other pro-inflammatory signaling pathways [<xref rid="B25-ncrna-11-00037" ref-type="bibr">25</xref>]. This means that while miR-146a exerts an inhibitory effect on NF-&#x003ba;B, other pathways may still promote its activation, maintaining inflammation in chronic periodontitis. In this context, inflammation is not a linear process but a network of dynamic interactions where multiple mediators regulate and modulate the immune response. This molecular interconnection makes it challenging to isolate the absolute effect of a single factor, which may explain why miR-146a overexpression does not result in a significant decrease in NF-&#x003ba;B and its pro-inflammatory cytokines, as observed in all biomolecular studies [<xref rid="B26-ncrna-11-00037" ref-type="bibr">26</xref>]. These findings confirm that periodontitis is a multifactorial disease, where inflammation regulation depends on a complex balance between multiple molecules and signaling pathways.</p><p>Systemic inflammation, triggered by obesity and amplified by periodontitis, constitutes a crucial link connecting these two disorders with the development of cardiovascular diseases. In this regard, Krutika Yagnik et al. (2019) [<xref rid="B16-ncrna-11-00037" ref-type="bibr">16</xref>] demonstrated a statistically significant correlation between periodontal and cardiac variables, BMI, and miRNA-146a levels in patients with both conditions [<xref rid="B27-ncrna-11-00037" ref-type="bibr">27</xref>].</p><p>The findings from animal models provide valuable insight into the actual impact of miR-143/145 on atherosclerosis accelerated by <italic toggle="yes">P. gingivalis.</italic> Modulation of this miRNA in mice directly influences disease progression, macrophage efferocytosis, and its interaction with Siglec-G, enhancing the understanding of underlying pathogenesis mechanisms. These results not only validate observations from in vitro studies but also open potential therapeutic approaches for human intervention [<xref rid="B20-ncrna-11-00037" ref-type="bibr">20</xref>].</p><p>Another studied microRNA, miR-155, is involved in several biological processes, including cell proliferation, immunity, and inflammation, and plays a role in inflammatory reactions and autoimmune diseases [<xref rid="B28-ncrna-11-00037" ref-type="bibr">28</xref>,<xref rid="B29-ncrna-11-00037" ref-type="bibr">29</xref>]. Zina A. Daily et al. (2023) [<xref rid="B22-ncrna-11-00037" ref-type="bibr">22</xref>] showed that patients with concurrent cardiovascular disease and periodontitis exhibited miR-155 expression levels 14.08 times higher in the blood compared to the control group.</p><p>In line with these findings, recent research has demonstrated that miR-155-5p-enriched exosomes derived from periodontal endothelial cells may play a key role in the progression of atherosclerosis. miR-155-5p has been found to be highly expressed in the plasma exosomes of patients with carotid atherosclerosis (CAS) and chronic periodontitis (CP), suggesting a cellular communication mechanism between these two pathologies. Additionally, bacterial products from periodontitis, such as lipopolysaccharide (LPS), have been shown to increase miR-155-5p expression, facilitating its transfer to vascular endothelial cells and promoting endothelial barrier disruption and angiogenesis. These results reinforce the hypothesis that periodontitis contributes to cardiovascular disease development through miR-155-mediated mechanisms [<xref rid="B13-ncrna-11-00037" ref-type="bibr">13</xref>,<xref rid="B30-ncrna-11-00037" ref-type="bibr">30</xref>].</p><p>Jieyu Zhou et al. (2022) [<xref rid="B18-ncrna-11-00037" ref-type="bibr">18</xref>] analyzed the pathogenicity of Fusobacterium nucleatum and observed that its infection was associated with increased periodontal parameters, the progression of atherosclerotic lesions, and an elevated expression of miR-146a, miR-155, and miR-23b. This microRNA is upregulated in individuals with cardiovascular diseases and found at lower levels in healthy subjects, as it plays a key role in cardiac development [<xref rid="B31-ncrna-11-00037" ref-type="bibr">31</xref>]. A similar study by Di et al. [<xref rid="B32-ncrna-11-00037" ref-type="bibr">32</xref>] aimed to investigate the role of this miRNA by analyzing circulating endothelial progenitor cells (EPCs), their neovascularization capacity, and their relationship with cardiovascular disease. The results showed that the inhibition of miR-23b promotes blood flow recovery in ischemic limbs in mice.</p><p>Among the miRNAs analyzed, miRNA-126 was the only one not found to be upregulated in patients with concomitant cardiovascular and periodontal disease [<xref rid="B15-ncrna-11-00037" ref-type="bibr">15</xref>]. This microRNA plays a key role in maintaining vascular homeostasis and modulating the inflammatory response, primarily through the negative regulation of pro-inflammatory cytokines and biomarkers that contribute to the amplification of inflammation in conditions such as atherosclerosis and diabetes. Its downregulation in affected individuals may reflect an impaired anti-inflammatory regulatory mechanism, thereby contributing to the progression of vascular and inflammatory damage associated with these comorbidities [<xref rid="B33-ncrna-11-00037" ref-type="bibr">33</xref>].</p><p>Other studies have found that microRNAs associated with other systemic inflammatory conditions, such as type 2 diabetes mellitus and obesity, include miR-146a, miR-155, miR-200b, miR-223, and miR-203 [<xref rid="B34-ncrna-11-00037" ref-type="bibr">34</xref>].</p><p>Previous studies, such as those by Radovic et al. (2018) [<xref rid="B35-ncrna-11-00037" ref-type="bibr">35</xref>] and Saito et al. (2017) [<xref rid="B36-ncrna-11-00037" ref-type="bibr">36</xref>], have reported elevated microRNA levels in the gingival crevicular fluid of periodontitis patients compared to healthy individuals. Specifically, Radovic et al. (2018) [<xref rid="B35-ncrna-11-00037" ref-type="bibr">35</xref>] evaluated miR-146a and miR-155 in patients with chronic periodontitis&#x02014;with and without type 2 diabetes mellitus&#x02014;observing a significant reduction in their expression after non-surgical periodontal treatment. This supports the hypothesis that miR-146a and miR-155 play a crucial role in periodontal inflammation regulation via TLR activation. Similarly, Almi&#x000f1;ana et al. (2023) [<xref rid="B9-ncrna-11-00037" ref-type="bibr">9</xref>], after conducting a comprehensive screening of all existing miRNAs, identified miR-199b-3p and miR-146a as the most potent biomarkers in a sample of chronic periodontitis patients.</p><p>Further research with well-designed studies could enhance the understanding of these biomarkers and their role in susceptibility to periodontitis and cardiovascular disease, contributing to the development of precision medicine.</p></sec><sec id="sec4-ncrna-11-00037"><title>4. Materials and Methods</title><p>This systematic review was conducted following the PRISMA 2020 (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) criteria [<xref rid="B37-ncrna-11-00037" ref-type="bibr">37</xref>]. The protocol was registered in PROSPERO under ID CRD420251023111.</p><list list-type="simple"><list-item><label>-</label><p>Review question.</p></list-item></list><p>The formulated Population, Exposure, Comparison, and Outcome (PECO) [<xref rid="B38-ncrna-11-00037" ref-type="bibr">38</xref>] question was as follows: Population (humans with myocardial ischemia and/or occlusive arterial disease), Exposure (periodontitis), Comparison (subjects with cardiovascular disorders but without periodontitis), and Outcome (miRNA expression levels). Therefore, the research question was &#x0201c;Do individuals with myocardial ischemia and/or occlusive arterial disease along with periodontitis exhibit greater alterations in miRNA expression levels compared to those with only cardiovascular disorders?&#x0201d;</p><list list-type="simple"><list-item><label>-</label><p>Inclusion and Exclusion Criteria.</p></list-item></list><p>Cohort studies, case-control studies, randomized controlled trials (RCTs), experimental studies using in vitro samples, and experimental studies on animals were included. Conversely, studies without a control group, case reports, systematic or literature reviews, and expert opinions were excluded.</p><list list-type="simple"><list-item><label>-</label><p>Search Strategy.</p></list-item></list><p>To formulate the search strategy, an initial terminological analysis was conducted. The process of formulating the search equations and their application in each of the databases was carried out by a single researcher (M.G.-S).</p><p>The search equation used was as follows: (MicroRNAs OR MicroRNA OR miRNA OR miRNAs OR &#x0201c;miRNAs&#x0201d; OR &#x0201c;Micro RNA&#x0201d; OR &#x0201c;Micro RNAs&#x0201d; OR &#x0201c;mi-RNA&#x0201d; OR &#x0201c;mi-RNAs&#x0201d; OR &#x0201c;mRNA&#x0201d; OR &#x0201c;mRNAs&#x0201d;) AND (&#x0201c;Periodontal disease&#x0201d; OR &#x0201c;Periodontal diseases&#x0201d; OR Periodontitis OR gingivitis OR Gingival OR Periodontal OR paradontoses OR paradontitis OR Chronic periodontitis) AND (&#x0201c;Myocardial Ischemia&#x0201d; OR &#x0201c;Ischemic Heart Diseases&#x0201d; OR &#x0201c;Ischemic Heart Disease&#x0201d; OR &#x0201c;Myocardial Ischemias&#x0201d; OR &#x0201c;Arterial Occlusive Diseases&#x0201d; OR &#x0201c;Arterial Occlusive Disease&#x0201d; OR &#x0201c;Arterial Obstructive Diseases&#x0201d; OR &#x0201c;Arterial Obstructive Disease&#x0201d; OR &#x0201c;Arterial Occlusion&#x0201d; OR &#x0201c;Arterial Occlusions&#x0201d; OR &#x0201c;Atherosclerosis&#x0201d; OR &#x0201c;Atheroscleroses&#x0201d; OR &#x0201c;Carotid artery diseases&#x0201d; OR &#x0201c;Carotid atherosclerosis&#x0201d; OR &#x0201c;Atherosclerotic plaque&#x0201d; OR &#x0201c;Atheroma&#x0201d; OR &#x0201c;Atheromas&#x0201d; OR &#x0201c;Atheromatous plaque&#x0201d; OR &#x0201c;Angina pectoris&#x0201d; OR &#x0201c;Acute coronary syndrome&#x0201d; OR &#x0201c;Peripheral arterial disease&#x0201d;).</p><p>To identify all studies addressing the PECO question, searches were conducted in the PubMed, Embase, Scopus, and Web of Science databases. No language or publication date filters were applied to prevent the loss of potentially relevant articles. The search process began on 31 December 2024 and concluded in January 2025.</p><p>The selection process was carried out by two reviewers (M.G.-S. and M.C.-V.), who evaluated the titles and abstracts of the articles available in the databases. To assess the level of agreement between the two reviewers, the inter-examiner agreement was measured using the Kappa coefficient. Additionally, duplicate articles were identified and removed. In cases of discrepancies, a third reviewer (P.A.-P.) was consulted.</p><p>If the title and abstract did not provide sufficient information to determine an article&#x02019;s eligibility, a full-text review was performed. After this initial phase, the selected articles underwent a complete review, and in cases of exclusion, the reasons for rejection were documented.</p><list list-type="simple"><list-item><label>-</label><p>Data Extraction and Variable Lists.</p></list-item></list><p>Two tables were designed to distinguish human studies from animal experimentation studies.</p><p>For both tables, including those for human studies and experimental studies, the following data were extracted: author and year, country, sample size, study type, studied miRNAs, other biomarkers analyzed, sample type, and miRNA expression results.</p><p>Additionally, in the table for human studies, variables related to periodontal stage and grade, as well as the results of periodontal parameters, were included. Conversely, in the table for experimental studies, an additional column was incorporated to summarize the conclusions of each study.</p><list list-type="simple"><list-item><label>-</label><p>Quality Assessment.</p></list-item></list><p>To assess the quality of the selected human studies, the Newcastle&#x02013;Ottawa Quality Assessment Scale (NOS) was used. This scale includes eight criteria evaluating different aspects of the study methodology. Each study can receive one point per fulfilled criterion, except for the comparability section, which allows for up to two points, resulting in a maximum score of nine points.</p><p>Similarly, to evaluate the quality of animal or in vitro experimental studies, the SYRCLE&#x02019;s Risk of Bias Tool was employed. In this tool, &#x0201c;Yes&#x0201d; indicates a low risk of bias, &#x0201c;No&#x0201d; indicates a high risk of bias, and &#x0201c;Unclear&#x0201d; signifies an uncertain risk of bias.</p></sec><sec sec-type="conclusions" id="sec5-ncrna-11-00037"><title>5. Conclusions</title><p>Within the limitations of this systematic review, the studies seem to indicate that miRNAs could be adequate biomarkers in the study of the interrelationship between cardiovascular disease and periodontitis. Studies should be designed to determine whether these markers in the GCF could indicate susceptibility to both periodontitis and cardiovascular disease and improve their value as biomarkers.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, M.G.-S.; methodology, A.L.-R. and M.C.-V.; data curation, P.A.-P.; writing&#x02014;original draft preparation, M.G.-S. and M.C.-V.; writing&#x02014;review and editing, A.L.-R. and P.A.-P.; supervision, A.L.-R. and P.A.-P. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>We have no complementary data; all the information regarding the methodology of this systematic review is reflected in this paper.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</p></notes><ref-list><title>References</title><ref id="B1-ncrna-11-00037"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Slots</surname><given-names>J.</given-names></name>
</person-group><article-title>Periodontitis: Facts, Fallacies and the Future</article-title><source>Periodontol. 2000</source><year>2017</year><volume>75</volume><fpage>7</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1111/prd.12221</pub-id><pub-id pub-id-type="pmid">28758294</pub-id>
</element-citation></ref><ref id="B2-ncrna-11-00037"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sanz</surname><given-names>M.</given-names></name>
<name><surname>Ceriello</surname><given-names>A.</given-names></name>
<name><surname>Buysschaert</surname><given-names>M.</given-names></name>
<name><surname>Chapple</surname><given-names>I.</given-names></name>
<name><surname>Demmer</surname><given-names>R.T.</given-names></name>
<name><surname>Graziani</surname><given-names>F.</given-names></name>
<name><surname>Herrera</surname><given-names>D.</given-names></name>
<name><surname>Jepsen</surname><given-names>S.</given-names></name>
<name><surname>Lione</surname><given-names>L.</given-names></name>
<name><surname>Madianos</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>Scientific Evidence on the Links between Periodontal Diseases and Diabetes: Consensus Report and Guidelines of the Joint Workshop on Periodontal Diseases and Diabetes by the International Diabetes Federation and the European Federation of Periodontology</article-title><source>J. Clin. Periodontol.</source><year>2018</year><volume>45</volume><fpage>138</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1111/jcpe.12808</pub-id><pub-id pub-id-type="pmid">29280174</pub-id>
</element-citation></ref><ref id="B3-ncrna-11-00037"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sanz</surname><given-names>M.</given-names></name>
<name><surname>Marco Del Castillo</surname><given-names>A.</given-names></name>
<name><surname>Jepsen</surname><given-names>S.</given-names></name>
<name><surname>Gonzalez-Juanatey</surname><given-names>J.R.</given-names></name>
<name><surname>D&#x02019;Aiuto</surname><given-names>F.</given-names></name>
<name><surname>Bouchard</surname><given-names>P.</given-names></name>
<name><surname>Chapple</surname><given-names>I.</given-names></name>
<name><surname>Dietrich</surname><given-names>T.</given-names></name>
<name><surname>Gotsman</surname><given-names>I.</given-names></name>
<name><surname>Graziani</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>Periodontitis and Cardiovascular Diseases: Consensus Report</article-title><source>J. Clin. Periodontol.</source><year>2020</year><volume>47</volume><fpage>268</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1111/jcpe.13189</pub-id><pub-id pub-id-type="pmid">32011025</pub-id>
</element-citation></ref><ref id="B4-ncrna-11-00037"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tonetti</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Periodontitis and Risk for Atherosclerosis: An Update on Intervention Trials</article-title><source>J. Clin. Periodontol.</source><year>2009</year><volume>36</volume><fpage>15</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1111/j.1600-051X.2009.01417.x</pub-id><pub-id pub-id-type="pmid">19432627</pub-id>
</element-citation></ref><ref id="B5-ncrna-11-00037"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Slade</surname><given-names>G.D.</given-names></name>
<name><surname>Ghezzi</surname><given-names>E.M.</given-names></name>
<name><surname>Heiss</surname><given-names>G.</given-names></name>
<name><surname>Beck</surname><given-names>J.D.</given-names></name>
<name><surname>Riche</surname><given-names>E.</given-names></name>
<name><surname>Offenbacher</surname><given-names>S.</given-names></name>
</person-group><article-title>Relationship Between Periodontal Disease and C-Reactive Protein Among Adults in the Atherosclerosis Risk in Communities Study</article-title><source>Arch. Intern. Med.</source><year>2003</year><volume>163</volume><fpage>1172</fpage><lpage>1179</lpage><pub-id pub-id-type="doi">10.1001/archinte.163.10.1172</pub-id><pub-id pub-id-type="pmid">12767953</pub-id>
</element-citation></ref><ref id="B6-ncrna-11-00037"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kurita-Ochiai</surname><given-names>T.</given-names></name>
<name><surname>Yamamoto</surname><given-names>M.</given-names></name>
</person-group><article-title>Periodontal Pathogens and Atherosclerosis: Implications of Inflammation and Oxidative Modification of LDL</article-title><source>BioMed Res. Int.</source><year>2014</year><volume>2014</volume><elocation-id>595981</elocation-id><pub-id pub-id-type="doi">10.1155/2014/595981</pub-id><pub-id pub-id-type="pmid">24949459</pub-id>
</element-citation></ref><ref id="B7-ncrna-11-00037"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kebschull</surname><given-names>M.</given-names></name>
<name><surname>Demmer</surname><given-names>R.T.</given-names></name>
<name><surname>Papapanou</surname><given-names>P.N.</given-names></name>
</person-group><article-title>&#x0201c;Gum Bug, Leave My Heart Alone !&#x0201d;&#x02014;Epidemiologic and Mechanistic Evidence Linking Periodontal Infections and Atherosclerosis</article-title><source>J. Dent. Res.</source><year>2010</year><volume>89</volume><fpage>879</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1177/0022034510375281</pub-id><pub-id pub-id-type="pmid">20639510</pub-id>
</element-citation></ref><ref id="B8-ncrna-11-00037"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dorn</surname><given-names>B.R.</given-names></name>
<name><surname>Dunn</surname><given-names>W.A.</given-names></name>
<name><surname>Progulske-Fox</surname><given-names>A.</given-names></name>
</person-group><article-title>Invasion of Human Coronary Artery Cells by Periodontal Pathogens</article-title><source>Infect. Immun.</source><year>1999</year><volume>67</volume><fpage>5792</fpage><lpage>5798</lpage><pub-id pub-id-type="doi">10.1128/IAI.67.11.5792-5798.1999</pub-id><pub-id pub-id-type="pmid">10531230</pub-id>
</element-citation></ref><ref id="B9-ncrna-11-00037"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Almi&#x000f1;ana-Pastor</surname><given-names>P.J.</given-names></name>
<name><surname>Alpiste-Illueca</surname><given-names>F.M.</given-names></name>
<name><surname>Mic&#x000f3;-Martinez</surname><given-names>P.</given-names></name>
<name><surname>Garc&#x000ed;a-Gim&#x000e9;nez</surname><given-names>J.L.</given-names></name>
<name><surname>Garc&#x000ed;a-L&#x000f3;pez</surname><given-names>E.</given-names></name>
<name><surname>L&#x000f3;pez-Rold&#x000e1;n</surname><given-names>A.</given-names></name>
</person-group><article-title>MicroRNAs in Gingival Crevicular Fluid: An Observational Case-Control Study of Differential Expression in Periodontitis</article-title><source>ncRNA</source><year>2023</year><volume>9</volume><elocation-id>73</elocation-id><pub-id pub-id-type="doi">10.3390/ncrna9060073</pub-id><pub-id pub-id-type="pmid">37987369</pub-id>
</element-citation></ref><ref id="B10-ncrna-11-00037"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mic&#x000f3;-Mart&#x000ed;nez</surname><given-names>P.</given-names></name>
<name><surname>Almi&#x000f1;ana-Pastor</surname><given-names>P.J.</given-names></name>
<name><surname>Alpiste-Illueca</surname><given-names>F.</given-names></name>
<name><surname>L&#x000f3;pez-Rold&#x000e1;n</surname><given-names>A.</given-names></name>
</person-group><article-title>MicroRNAs and Periodontal Disease: A Qualitative Systematic Review of Human Studies</article-title><source>J. Periodontal Implant Sci.</source><year>2021</year><volume>51</volume><fpage>386</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.5051/jpis.2007540377</pub-id><pub-id pub-id-type="pmid">34965618</pub-id>
</element-citation></ref><ref id="B11-ncrna-11-00037"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Oliveira</surname><given-names>N.F.P.</given-names></name>
<name><surname>Andia</surname><given-names>D.C.</given-names></name>
<name><surname>Planello</surname><given-names>A.C.</given-names></name>
<name><surname>Pasetto</surname><given-names>S.</given-names></name>
<name><surname>Marques</surname><given-names>M.R.</given-names></name>
<name><surname>Nociti</surname><given-names>F.H.</given-names><suffix>Jr.</suffix></name>
<name><surname>Line</surname><given-names>S.R.P.</given-names></name>
<name><surname>De Souza</surname><given-names>A.P.</given-names></name>
</person-group><article-title>TLR2 and TLR4 Gene Promoter Methylation Status during Chronic Periodontitis</article-title><source>J Clin. Periodontol.</source><year>2011</year><volume>38</volume><fpage>975</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1111/j.1600-051X.2011.01765.x</pub-id><pub-id pub-id-type="pmid">21899586</pub-id>
</element-citation></ref><ref id="B12-ncrna-11-00037"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Loo</surname><given-names>W.T.</given-names></name>
<name><surname>Jin</surname><given-names>L.</given-names></name>
<name><surname>Cheung</surname><given-names>M.N.</given-names></name>
<name><surname>Wang</surname><given-names>M.</given-names></name>
<name><surname>Chow</surname><given-names>L.W.</given-names></name>
</person-group><article-title>Epigenetic Change in E-Cardherin and COX-2 to Predict Chronic Periodontitis</article-title><source>J. Transl. Med.</source><year>2010</year><volume>8</volume><fpage>110</fpage><pub-id pub-id-type="doi">10.1186/1479-5876-8-110</pub-id><pub-id pub-id-type="pmid">21047437</pub-id>
</element-citation></ref><ref id="B13-ncrna-11-00037"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>W.-W.</given-names></name>
<name><surname>Li</surname><given-names>Q.-X.</given-names></name>
<name><surname>Wang</surname><given-names>F.</given-names></name>
<name><surname>Zhang</surname><given-names>X.-R.</given-names></name>
<name><surname>Zhang</surname><given-names>X.-L.</given-names></name>
<name><surname>Wang</surname><given-names>M.</given-names></name>
<name><surname>Xue</surname><given-names>D.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.</given-names></name>
<name><surname>Tang</surname><given-names>L.</given-names></name>
</person-group><article-title>Exosomal miR-155-5p Promote the Occurrence of Carotid Atherosclerosis</article-title><source>J. Cell. Mol. Med.</source><year>2024</year><volume>28</volume><fpage>e70187</fpage><pub-id pub-id-type="doi">10.1111/jcmm.70187</pub-id><pub-id pub-id-type="pmid">39495676</pub-id>
</element-citation></ref><ref id="B14-ncrna-11-00037"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bagavad Gita</surname><given-names>J.</given-names></name>
<name><surname>George</surname><given-names>A.V.</given-names></name>
<name><surname>Pavithra</surname><given-names>N.</given-names></name>
<name><surname>Chandrasekaran</surname><given-names>S.C.</given-names></name>
<name><surname>Latchumanadhas</surname><given-names>K.</given-names></name>
<name><surname>Gnanamani</surname><given-names>A.</given-names></name>
</person-group><article-title>Dysregulation of miR-146a by Periodontal Pathogens: A Risk for Acute Coronary Syndrome</article-title><source>J. Periodontol.</source><year>2019</year><volume>90</volume><fpage>756</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1002/JPER.18-0466</pub-id><pub-id pub-id-type="pmid">30618100</pub-id>
</element-citation></ref><ref id="B15-ncrna-11-00037"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mahendra</surname><given-names>J.</given-names></name>
<name><surname>Mahendra</surname><given-names>L.</given-names></name>
<name><surname>Fageeh</surname><given-names>H.N.</given-names></name>
<name><surname>Fageeh</surname><given-names>H.I.</given-names></name>
<name><surname>Ibraheem</surname><given-names>W.</given-names></name>
<name><surname>Abdulkarim</surname><given-names>H.H.</given-names></name>
<name><surname>Kanakamedala</surname><given-names>A.</given-names></name>
<name><surname>Prakash</surname><given-names>P.</given-names></name>
<name><surname>Srinivasan</surname><given-names>S.</given-names></name>
<name><surname>Balaji</surname><given-names>T.M.</given-names></name>
<etal/>
</person-group><article-title>miRNA-146a and miRNA-126 as Potential Biomarkers in Patients with Coronary Artery Disease and Generalized Periodontitis</article-title><source>Materials</source><year>2021</year><volume>14</volume><elocation-id>4692</elocation-id><pub-id pub-id-type="doi">10.3390/ma14164692</pub-id><pub-id pub-id-type="pmid">34443215</pub-id>
</element-citation></ref><ref id="B16-ncrna-11-00037"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yagnik</surname><given-names>K.</given-names></name>
<name><surname>Mahendra</surname><given-names>J.</given-names></name>
<name><surname>Kurian</surname><given-names>V.M.</given-names></name>
</person-group><article-title>The Periodontal-Cardiovascular Alliance: Evaluation of miRNA-146a in Subgingival Plaque Samples of Chronic Periodontitis Patients with and without Coronary Heart Disease</article-title><source>J. Investig. Clin. Dent.</source><year>2019</year><volume>10</volume><fpage>e12442</fpage><pub-id pub-id-type="doi">10.1111/jicd.12442</pub-id></element-citation></ref><ref id="B17-ncrna-11-00037"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Caton</surname><given-names>J.G.</given-names></name>
<name><surname>Armitage</surname><given-names>G.</given-names></name>
<name><surname>Berglundh</surname><given-names>T.</given-names></name>
<name><surname>Chapple</surname><given-names>I.L.C.</given-names></name>
<name><surname>Jepsen</surname><given-names>S.</given-names></name>
<name><surname>Kornman</surname><given-names>K.S.</given-names></name>
<name><surname>Mealey</surname><given-names>B.L.</given-names></name>
<name><surname>Papapanou</surname><given-names>P.N.</given-names></name>
<name><surname>Sanz</surname><given-names>M.</given-names></name>
<name><surname>Tonetti</surname><given-names>M.S.</given-names></name>
</person-group><article-title>A New Classification Scheme for Periodontal and Peri-implant Diseases and Conditions&#x02014;Introduction and Key Changes from the 1999 Classification</article-title><source>J. Clin. Periodontol.</source><year>2018</year><volume>45</volume><fpage>S1</fpage><lpage>S8</lpage><pub-id pub-id-type="doi">10.1111/jcpe.12935</pub-id><pub-id pub-id-type="pmid">29926489</pub-id>
</element-citation></ref><ref id="B18-ncrna-11-00037"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>Wu</surname><given-names>P.</given-names></name>
<name><surname>Zhao</surname><given-names>L.</given-names></name>
<name><surname>Wu</surname><given-names>Y.</given-names></name>
</person-group><article-title>Fusobacterium Nucleatum Accelerates Atherosclerosis via Macrophage-Driven Aberrant Proinflammatory Response and Lipid Metabolism</article-title><source>Front. Microbiol.</source><year>2022</year><volume>13</volume><elocation-id>798685</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2022.798685</pub-id><pub-id pub-id-type="pmid">35359716</pub-id>
</element-citation></ref><ref id="B19-ncrna-11-00037"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nahid</surname><given-names>M.A.</given-names></name>
<name><surname>Rivera</surname><given-names>M.</given-names></name>
<name><surname>Lucas</surname><given-names>A.</given-names></name>
<name><surname>Chan</surname><given-names>E.K.L.</given-names></name>
<name><surname>Kesavalu</surname><given-names>L.</given-names></name>
</person-group><article-title>Polymicrobial Infection with Periodontal Pathogens Specifically Enhances microRNA miR-146a in ApoE-/- Mice during Experimental Periodontal Disease</article-title><source>Infect. Immun.</source><year>2011</year><volume>79</volume><fpage>1597</fpage><lpage>1605</lpage><pub-id pub-id-type="doi">10.1128/IAI.01062-10</pub-id><pub-id pub-id-type="pmid">21263019</pub-id>
</element-citation></ref><ref id="B20-ncrna-11-00037"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xie</surname><given-names>H.</given-names></name>
<name><surname>Qin</surname><given-names>Z.</given-names></name>
<name><surname>Ling</surname><given-names>Z.</given-names></name>
<name><surname>Ge</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Guo</surname><given-names>S.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>Zheng</surname><given-names>K.</given-names></name>
<name><surname>Jiang</surname><given-names>H.</given-names></name>
<name><surname>Xu</surname><given-names>R.</given-names></name>
</person-group><article-title>Oral Pathogen Aggravates Atherosclerosis by Inducing Smooth Muscle Cell Apoptosis and Repressing Macrophage Efferocytosis</article-title><source>Int. J. Oral Sci.</source><year>2023</year><volume>15</volume><fpage>26</fpage><pub-id pub-id-type="doi">10.1038/s41368-023-00232-5</pub-id><pub-id pub-id-type="pmid">37380627</pub-id>
</element-citation></ref><ref id="B21-ncrna-11-00037"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hooijmans</surname><given-names>C.R.</given-names></name>
<name><surname>Rovers</surname><given-names>M.M.</given-names></name>
<name><surname>De Vries</surname><given-names>R.B.</given-names></name>
<name><surname>Leenaars</surname><given-names>M.</given-names></name>
<name><surname>Ritskes-Hoitinga</surname><given-names>M.</given-names></name>
<name><surname>Langendam</surname><given-names>M.W.</given-names></name>
</person-group><article-title>SYRCLE&#x02019;s Risk of Bias Tool for Animal Studies</article-title><source>BMC Med. Res. Methodol.</source><year>2014</year><volume>14</volume><elocation-id>43</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2288-14-43</pub-id><pub-id pub-id-type="pmid">24667063</pub-id>
</element-citation></ref><ref id="B22-ncrna-11-00037"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Daily</surname><given-names>Z.A.</given-names></name>
<name><surname>Al-Ghurabi</surname><given-names>B.H.</given-names></name>
<name><surname>Al-Qarakhli</surname><given-names>A.M.A.</given-names></name>
<name><surname>Moseley</surname><given-names>R.</given-names></name>
</person-group><article-title>MicroRNA-155 (miR-155) as an Accurate Biomarker of Periodontal Status and Coronary Heart Disease Severity: A Case-Control Study</article-title><source>BMC Oral Health</source><year>2023</year><volume>23</volume><elocation-id>868</elocation-id><pub-id pub-id-type="doi">10.1186/s12903-023-03584-w</pub-id><pub-id pub-id-type="pmid">37974134</pub-id>
</element-citation></ref><ref id="B23-ncrna-11-00037"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alminana-Pastor</surname><given-names>P.</given-names></name>
<name><surname>Boronat-Catala</surname><given-names>M.</given-names></name>
<name><surname>Mico-Martinez</surname><given-names>P.</given-names></name>
<name><surname>Bellot-Arcis</surname><given-names>C.</given-names></name>
<name><surname>Lopez-Rolda</surname><given-names>A.</given-names></name>
<name><surname>Alpiste-Illueca</surname><given-names>F.</given-names></name>
</person-group><article-title>Epigenetics and Periodontics: A Systematic Review</article-title><source>Med. Oral</source><year>2019</year><volume>24</volume><fpage>e659</fpage><lpage>e672</lpage><pub-id pub-id-type="doi">10.4317/medoral.23008</pub-id></element-citation></ref><ref id="B24-ncrna-11-00037"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Motedayyen</surname><given-names>H.</given-names></name>
<name><surname>Ghotloo</surname><given-names>S.</given-names></name>
<name><surname>Saffari</surname><given-names>M.</given-names></name>
<name><surname>Sattari</surname><given-names>M.</given-names></name>
<name><surname>Amid</surname><given-names>R.</given-names></name>
</person-group><article-title>Evaluation of MicroRNA-146a and Its Targets in Gingival Tissues of Patients With Chronic Periodontitis</article-title><source>J. Periodontol.</source><year>2015</year><volume>86</volume><fpage>1380</fpage><lpage>1385</lpage><pub-id pub-id-type="doi">10.1902/jop.2015.150319</pub-id><pub-id pub-id-type="pmid">26313020</pub-id>
</element-citation></ref><ref id="B25-ncrna-11-00037"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arabaci</surname><given-names>T.</given-names></name>
<name><surname>Cicek</surname><given-names>Y.</given-names></name>
<name><surname>Canakci</surname><given-names>V.</given-names></name>
<name><surname>Canakci</surname><given-names>C.F.</given-names></name>
<name><surname>Ozgoz</surname><given-names>M.</given-names></name>
<name><surname>Albayrak</surname><given-names>M.</given-names></name>
<name><surname>Keles</surname><given-names>O.N.</given-names></name>
</person-group><article-title>Immunohistochemical and Stereologic Analysis of NF-&#x003ba;B Activation in Chronic Periodontitis</article-title><source>Eur. J. Dent.</source><year>2010</year><volume>4</volume><fpage>454</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">20922166</pub-id>
</element-citation></ref><ref id="B26-ncrna-11-00037"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Honda</surname><given-names>T.</given-names></name>
<name><surname>Takahashi</surname><given-names>N.</given-names></name>
<name><surname>Miyauchi</surname><given-names>S.</given-names></name>
<name><surname>Yamazaki</surname><given-names>K.</given-names></name>
</person-group><article-title>Porphyromonas Gingivalis Lipopolysaccharide Induces miR-146a without Altering the Production of Inflammatory Cytokines</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2012</year><volume>420</volume><fpage>918</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2012.03.102</pub-id><pub-id pub-id-type="pmid">22480686</pub-id>
</element-citation></ref><ref id="B27-ncrna-11-00037"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Genco</surname><given-names>R.J.</given-names></name>
<name><surname>Grossi</surname><given-names>S.G.</given-names></name>
<name><surname>Ho</surname><given-names>A.</given-names></name>
<name><surname>Nishimura</surname><given-names>F.</given-names></name>
<name><surname>Murayama</surname><given-names>Y.</given-names></name>
</person-group><article-title>A Proposed Model Linking Inflammation to Obesity, Diabetes, and Periodontal Infections</article-title><source>J. Periodontol.</source><year>2005</year><volume>76</volume><fpage>2075</fpage><lpage>2084</lpage><pub-id pub-id-type="doi">10.1902/jop.2005.76.11-S.2075</pub-id></element-citation></ref><ref id="B28-ncrna-11-00037"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Song</surname><given-names>J.</given-names></name>
<name><surname>Hu</surname><given-names>Y.</given-names></name>
<name><surname>Jiang</surname><given-names>X.</given-names></name>
<name><surname>Zhu</surname><given-names>W.</given-names></name>
<name><surname>Wu</surname><given-names>Z.</given-names></name>
<name><surname>Dong</surname><given-names>S.</given-names></name>
</person-group><article-title>Profiling of Novel microRNAs Elicited by EV71 and CA16 Infection in Human Bronchial Epithelial Cells Using High-Throughput Sequencing</article-title><source>Virus Res.</source><year>2018</year><volume>247</volume><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2018.02.008</pub-id><pub-id pub-id-type="pmid">29447975</pub-id>
</element-citation></ref><ref id="B29-ncrna-11-00037"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Suo</surname><given-names>T.</given-names></name>
<name><surname>Chen</surname><given-names>G.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Zhao</surname><given-names>K.</given-names></name>
<name><surname>Wang</surname><given-names>T.</given-names></name>
<name><surname>Hu</surname><given-names>K.</given-names></name>
</person-group><article-title>miRNA-1246 Suppresses Acute Lung Injury-Induced Inflammation and Apoptosis via the NF-&#x003ba;B and Wnt/&#x003b2;-Catenin Signal Pathways</article-title><source>Biomed. Pharmacother.</source><year>2018</year><volume>108</volume><fpage>783</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.09.046</pub-id><pub-id pub-id-type="pmid">30253370</pub-id>
</element-citation></ref><ref id="B30-ncrna-11-00037"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maucher</surname><given-names>D.</given-names></name>
<name><surname>Schmidt</surname><given-names>B.</given-names></name>
<name><surname>Schumann</surname><given-names>J.</given-names></name>
</person-group><article-title>Loss of Endothelial Barrier Function in the Inflammatory Setting: Indication for a Cytokine-Mediated Post-Transcriptional Mechanism by Virtue of Upregulation of miRNAs miR-29a-3p, miR-29b-3p, and miR-155-5p</article-title><source>Cells</source><year>2021</year><volume>10</volume><elocation-id>2843</elocation-id><pub-id pub-id-type="doi">10.3390/cells10112843</pub-id><pub-id pub-id-type="pmid">34831066</pub-id>
</element-citation></ref><ref id="B31-ncrna-11-00037"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>X.</given-names></name>
<name><surname>He</surname><given-names>S.</given-names></name>
<name><surname>Wara</surname><given-names>A.K.M.</given-names></name>
<name><surname>Icli</surname><given-names>B.</given-names></name>
<name><surname>Shvartz</surname><given-names>E.</given-names></name>
<name><surname>Tesmenitsky</surname><given-names>Y.</given-names></name>
<name><surname>Belkin</surname><given-names>N.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Blackwell</surname><given-names>T.S.</given-names></name>
<name><surname>Sukhova</surname><given-names>G.K.</given-names></name>
<etal/>
</person-group><article-title>Systemic Delivery of MicroRNA-181b Inhibits Nuclear Factor-&#x003ba;B Activation, Vascular Inflammation, and Atherosclerosis in Apolipoprotein E&#x02013;Deficient Mice</article-title><source>Circ. Res.</source><year>2014</year><volume>114</volume><fpage>32</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.302089</pub-id><pub-id pub-id-type="pmid">24084690</pub-id>
</element-citation></ref><ref id="B32-ncrna-11-00037"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Di</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>D.</given-names></name>
<name><surname>Hu</surname><given-names>T.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
</person-group><article-title>miR-23 Regulate the Pathogenesis of Patients with Coronary Artery Disease</article-title><source>Int. J. Clin. Exp. Med.</source><year>2015</year><volume>8</volume><fpage>11759</fpage><lpage>11769</lpage><pub-id pub-id-type="pmid">26380016</pub-id>
</element-citation></ref><ref id="B33-ncrna-11-00037"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Lian</surname><given-names>Y.</given-names></name>
<name><surname>Wen</surname><given-names>X.</given-names></name>
<name><surname>Guo</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Jiang</surname><given-names>S.</given-names></name>
<name><surname>Hu</surname><given-names>Y.</given-names></name>
</person-group><article-title>Expression of miR-126 and Its Potential Function in Coronary Artery Disease</article-title><source>Afr. Health Sci.</source><year>2017</year><volume>17</volume><fpage>474</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.4314/ahs.v17i2.22</pub-id><pub-id pub-id-type="pmid">29062343</pub-id>
</element-citation></ref><ref id="B34-ncrna-11-00037"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mata-Monterde</surname><given-names>M.</given-names></name>
<name><surname>Serrano-Valcarce</surname><given-names>A.</given-names></name>
<name><surname>Almi&#x000f1;ana-Pastor</surname><given-names>P.J.</given-names></name>
<name><surname>Mic&#x000f3;-Mart&#x000ed;nez</surname><given-names>P.</given-names></name>
<name><surname>L&#x000f3;pez-Rold&#x000e1;n</surname><given-names>A.</given-names></name>
</person-group><article-title>miRNAs as Epigenetic Biomarkers in the Study of the Bidirectional Relationship between Type 2 Diabetes Mellitus and Periodontitis: A Systematic Review</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>10723</elocation-id><pub-id pub-id-type="doi">10.3390/ijms251910723</pub-id><pub-id pub-id-type="pmid">39409052</pub-id>
</element-citation></ref><ref id="B35-ncrna-11-00037"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Radovi&#x00107;</surname><given-names>N.</given-names></name>
<name><surname>Nikoli&#x00107; Jakoba</surname><given-names>N.</given-names></name>
<name><surname>Petrovi&#x00107;</surname><given-names>N.</given-names></name>
<name><surname>Milosavljevi&#x00107;</surname><given-names>A.</given-names></name>
<name><surname>Brkovi&#x00107;</surname><given-names>B.</given-names></name>
<name><surname>Roganovi&#x00107;</surname><given-names>J.</given-names></name>
</person-group><article-title>MicroRNA-146a and microRNA-155 as Novel Crevicular Fluid Biomarkers for Periodontitis in Non-Diabetic and Type 2 Diabetic Patients</article-title><source>J. Clin. Periodontol.</source><year>2018</year><volume>45</volume><fpage>663</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1111/jcpe.12888</pub-id><pub-id pub-id-type="pmid">29517812</pub-id>
</element-citation></ref><ref id="B36-ncrna-11-00037"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saito</surname><given-names>A.</given-names></name>
<name><surname>Horie</surname><given-names>M.</given-names></name>
<name><surname>Ejiri</surname><given-names>K.</given-names></name>
<name><surname>Aoki</surname><given-names>A.</given-names></name>
<name><surname>Katagiri</surname><given-names>S.</given-names></name>
<name><surname>Maekawa</surname><given-names>S.</given-names></name>
<name><surname>Suzuki</surname><given-names>S.</given-names></name>
<name><surname>Kong</surname><given-names>S.</given-names></name>
<name><surname>Yamauchi</surname><given-names>T.</given-names></name>
<name><surname>Yamaguchi</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>MicroRNA Profiling in Gingival Crevicular Fluid of Periodontitis-a Pilot Study</article-title><source>FEBS Open Bio</source><year>2017</year><volume>7</volume><fpage>981</fpage><lpage>994</lpage><pub-id pub-id-type="doi">10.1002/2211-5463.12238</pub-id></element-citation></ref><ref id="B37-ncrna-11-00037"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Page</surname><given-names>M.J.</given-names></name>
<name><surname>McKenzie</surname><given-names>J.E.</given-names></name>
<name><surname>Bossuyt</surname><given-names>P.M.</given-names></name>
<name><surname>Boutron</surname><given-names>I.</given-names></name>
<name><surname>Hoffmann</surname><given-names>T.C.</given-names></name>
<name><surname>Mulrow</surname><given-names>C.D.</given-names></name>
<name><surname>Shamseer</surname><given-names>L.</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J.M.</given-names></name>
<name><surname>Akl</surname><given-names>E.A.</given-names></name>
<name><surname>Brennan</surname><given-names>S.E.</given-names></name>
<etal/>
</person-group><article-title>The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><fpage>n71</fpage><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmid">33782057</pub-id>
</element-citation></ref><ref id="B38-ncrna-11-00037"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>R.L.</given-names></name>
<name><surname>Whaley</surname><given-names>P.</given-names></name>
<name><surname>Thayer</surname><given-names>K.A.</given-names></name>
<name><surname>Sch&#x000fc;nemann</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Identifying the PECO: A Framework for Formulating Good Questions to Explore the Association of Environmental and Other Exposures with Health Outcomes</article-title><source>Environ. Int.</source><year>2018</year><volume>121</volume><fpage>1027</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2018.07.015</pub-id><pub-id pub-id-type="pmid">30166065</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="ncrna-11-00037-f001"><label>Figure 1</label><caption><p>PRISMA flow diagram of the search process across the different databases.</p></caption><graphic xlink:href="ncrna-11-00037-g001" position="float"/></fig></floats-group></article>